Clinical Trial Update: Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients [Phase 2]

View source ↗

Summary

Phase 2 safety study evaluating escalating doses of TC-3 Gel in combination with intravesical mitomycin C for non-muscle invasive bladder cancer; the trial has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Mitomycin-C (mitomycin C)
• TC-3 Gel (TC-3 Gel)

Snippet

Sponsor: UroGen Pharma Ltd. | Conditions: Bladder Cancer, Neoplasms | Phase 2 | Status: COMPLETED